Joshua Hare Biography and Net Worth

Insider of Longeveron

Dr. Hare co-founded Longeveron in 2014 and serves as Chairman of the Board of Directors, and Chief Science Officer. Dr. Hare is a double board-certified cardiologist (Cardiology and Advanced Heart Failure and Transplantation) and is the founding director of the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. He has obtained in excess of $25 Million in funding from the National Institutes of Health over the past 15 years to support basic research of cell therapy strategies. He is also a recipient of the Paul Beeson Physician Faculty Scholar in Aging Research Award, and is an elected member of the American Association of Physicians, The American Society for Clinical Investigation, and is an elected Fellow of the American Heart Association. Dr. Hare has also served in numerous leadership roles at the American Heart Association and at the Center for Scientific Review of the National Institutes of Health. Dr. Hare is also a co-founder of Vestion, Inc., and Heart Genomics, LLC, companies that hold cardio-related intellectual property. He received a BA from the University of Pennsylvania, and his MD from The Johns Hopkins University School of Medicine, and completed fellowships at Johns Hopkins and Brigham and Women’s Hospital, and was a Research Fellow at Harvard Medical School.

What is Joshua Hare's net worth?: The estimated net worth of Joshua Hare is at least $1.20 million as of April 10th, 2024. Dr. Hare owns 590,727 shares of Longeveron stock worth more than $1,199,176 as of November 2nd. This net worth evaluation does not reflect any other assets that Dr. Hare may own. Additionally, Dr. Hare receives a salary of $74,000.00 as Insider at Longeveron. Learn More about Joshua Hare's net worth.
How old is Joshua Hare?: Dr. Hare is currently 61 years old. There are 7 older executives and no younger executives at Longeveron. The oldest executive at Longeveron is Ms. Lisa A. Locklear M.B.A., CFO & Treasurer, who is 63 years old. Learn More on Joshua Hare's age.
What is Joshua Hare's salary?: As the Insider of Longeveron Inc., Dr. Hare earns $74,000.00 per year. There are 3 executives that earn more than Dr. Hare. The highest earning executive at Longeveron is Mr. Mohamed Wa'el Ahmed Hashad M.B.A., CEO & Director, who commands a salary of $867,850.00 per year. Learn More on Joshua Hare's salary.
How do I contact Joshua Hare?: The corporate mailing address for Dr. Hare and other Longeveron executives is 1951 NW 7TH AVENUE SUITE 520, MIAMI FL, 33136. Longeveron can also be reached via phone at 305-302-7158 and via email at [email protected]. Learn More on Joshua Hare's contact information.
Has Joshua Hare been buying or selling shares of Longeveron?: Joshua Hare has not been actively trading shares of Longeveron within the last three months. Most recently, on Wednesday, April 10th, Joshua Hare bought 106,383 shares of Longeveron stock. The stock was acquired at an average cost of $2.35 per share, with a total value of $250,000.05. Following the completion of the transaction, the insider now directly owns 590,727 shares of the company's stock, valued at $1,388,208.45. Learn More on Joshua Hare's trading history.
Who are Longeveron's active insiders?: Longeveron's insider roster includes James Clavijo (CFO), Geoff Green (CEO), Joshua Hare (Insider), Paul Lehr (General Counsel), and Rock Soffer (Director). Learn More on Longeveron's active insiders.
Are insiders buying or selling shares of Longeveron?: During the last year, Longeveron insiders bought shares 5 times. They purchased a total of 150,436 shares worth more than $370,049.60. The most recent insider tranaction occured on April, 11th when CEO Mohamed Wa'el Ahmed Hashad bought 10,638 shares worth more than $24,999.30. Insiders at Longeveron own 19.1% of the company. Learn More about insider trades at Longeveron.
Information on this page was last updated on 4/11/2024.

Joshua Hare Insider Trading History at Longeveron

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/10/2024	Buy	106,383	$2.35	$250,000.05	590,727
1/27/2023	Sell	2,000	$42.80	$85,600.00	779,326
12/2/2022	Sell	2,000	$37.40	$74,800.00	781,326
10/12/2022	Sell	10,000	$36.10	$361,000.00	781,326
4/18/2022	Sell	1,992	$100.00	$199,200.00	791,334
10/12/2021	Buy	250	$36.90	$9,225.00
10/7/2021	Buy	198	$33.80	$6,692.40

Joshua Hare Buying and Selling Activity at Longeveron

Longeveron Company Overview

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Today's Range

Now: $2.03

$2.03

$2.12

50 Day Range

MA: $2.03

$1.78

$2.41

2 Week Range

Now: $2.03

$0.77

$23.90

Volume

379,146 shs

Average Volume

3,983,970 shs

Market Capitalization

$29.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

Joshua Hare Biography and Net Worth

What is Joshua Hare's net worth?

How old is Joshua Hare?

What is Joshua Hare's salary?

How do I contact Joshua Hare?

Has Joshua Hare been buying or selling shares of Longeveron?

Who are Longeveron's active insiders?

Are insiders buying or selling shares of Longeveron?